Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma

BACKGROUND/AIMS: Antiviral therapy is a key component in the management of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients. However, whether the potent drug entecavir is more effective than a less potent drug, such as lamivudine, in HBV-related HCC is not clear. METHODS: A re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut Liver
Autors principals: Kim, Jung Hee, Sinn, Dong Hyun, Kim, Kyunga, Kim, Hyeseung, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Format: Artigo
Idioma:Inglês
Publicat: Editorial Office of Gut and Liver 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087934/
https://ncbi.nlm.nih.gov/pubmed/27282264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15527
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars